CervoMed (CRVO) Return on Sales [ROS] (2011 - 2026)
CervoMed (CRVO) posted Return on Sales [ROS] of -9406.96% for Q2 2026, down 9030.55 percentage points from -376.41% a year earlier and down 7918.10 percentage points from the prior quarter.
Powered by 
Analysis
CervoMed (CRVO) Return on Sales [ROS] (2011 - 2026) Analysis & Trends
For FY2025, CervoMed's Return on Sales [ROS] came in at -706.22%, down 519.05 percentage points from FY2024.
- In prior years, CervoMed's Return on Sales [ROS] was -187.18% in FY2024 (-77.83 pp) and -109.35% in FY2023.
- Quarterly Return on Sales [ROS] has run from a low of -95479.25% in Q4 2025 to a high of -71.57% in Q2 2023 over five years.
- On a year-over-year basis, Return on Sales [ROS] has declined in each of the last ten quarters, with an average year-over-year change of -13549.05 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q3 2023, with a gain of 18201.35 percentage points; the weakest was Q4 2025, with a drop of 95144.33 percentage points.
- According to Business Quant data, Return on Sales [ROS] for the three prior quarters was -1488.86% (Q1 2026), -95479.25% (Q4 2025) and -2493.79% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 28.37% |
| 10 | CervoMed | 23.66 Mn | -62.36 Mn | - | -9,406.96% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9,406.96% |
| Mar 31, 2026 | -1,488.86% |
| Dec 31, 2025 | -95,479.25% |
| Sep 30, 2025 | -2,493.79% |
| Jun 30, 2025 | -376.41% |
| Mar 31, 2025 | -276.55% |
| Dec 31, 2024 | -334.91% |
| Sep 30, 2024 | -278.19% |
| Jun 30, 2024 | -91.06% |
| Mar 31, 2024 | -110.55% |
| Dec 31, 2023 | -99.59% |
| Sep 30, 2023 | -175.25% |
| Jun 30, 2023 | -71.57% |
| Mar 31, 2023 | -101.31% |
| Dec 31, 2022 | -12,794.31% |
| Sep 30, 2022 | -17,720.61% |
| Jun 30, 2022 | -7,667.09% |
| Mar 31, 2022 | -16,377.61% |
| Dec 31, 2021 | -17,948.68% |
| Sep 30, 2021 | -25,032.53% |
API Access
CervoMed Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CRVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "CRVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=CRVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();